MHB046C Injection

MHB046C · Minghui Pharmaceutical (Hangzhou) Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MHB046C Injection, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MHB046C Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]